Disorders of the autonomic nervous system.  Chapter 2. Relavant aspects of pharmacology.
D000109:Acetylcholine / Q000494:pharmacology; D000313:Adrenal Medulla / Q000294:innervation; D018663:Adrenergic Agents / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000187:drug effects*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D006801:Humans; D009638:Norepinephrine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D012701:Serotonin / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology
D018663:Adrenergic Agents; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D010276:Parasympatholytics; D010277:Parasympathomimetics; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D013566:Sympathomimetics; D012701:Serotonin; D001285:Atropine; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine